Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 11

Results: 15

TIGIT: a novel immunotherapy target moving from bench to bedside.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1659, doi. 10.1007/s00262-018-2246-5
By:
- Solomon, Benjamin L.;
- Garrido-Laguna, Ignacio
Publication type:
Article
Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1797, doi. 10.1007/s00262-018-2242-9
By:
- Weber, Alexander N. R.;
- Cardona Gloria, Yamel;
- Çınar, Özcan;
- Reinhardt, H. Christian;
- Pezzutto, Antonio;
- Wolz, Olaf-Oliver
Publication type:
Article
International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1809, doi. 10.1007/s00262-018-2240-y
By:
- Berraondo, Pedro;
- Aznar, Maria Angela;
- Perez-Ruiz, Elisabeth;
- Rodriguez-Ruiz, Maria Esperanza;
- Castañon, Eduardo;
- Perez-Gracia, Jose Luis;
- Melero, Ignacio
Publication type:
Article
TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1719, doi. 10.1007/s00262-018-2237-6
By:
- Jin, Ya-bin;
- Luo, Wei;
- Zhang, Guo-yi;
- Lin, Kai-rong;
- Cui, Jin-huan;
- Chen, Xiang-ping;
- Pan, Ying-ming;
- Mao, Xiao-fan;
- Tang, Jun;
- Wang, Yue-jian
Publication type:
Article
Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1731, doi. 10.1007/s00262-018-2234-9
By:
- Alexander, Matthew P.;
- Fiering, Steven N.;
- Ostroff, Gary R.;
- Cramer, Robert A.;
- Mullins, David W.
Publication type:
Article
Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1777, doi. 10.1007/s00262-018-2232-y
By:
- Yao, Yu;
- Luo, Feifei;
- Tang, Chao;
- Chen, Dikang;
- Qin, Zhiyong;
- Hua, Wei;
- Xu, Ming;
- Zhong, Ping;
- Yu, Shuangquan;
- Chen, Di;
- Ding, Xiaojie;
- Zhang, Yi;
- Zheng, Xiujuan;
- Yang, Jiao;
- Qian, Jiawen;
- Deng, Yuting;
- Hoon, Dave S. B.;
- Hu, Jian;
- Chu, Yiwei;
- Zhou, Liangfu
Publication type:
Article
PD-1/PD-L1 co-inhibition shapes anticancer T cell immunodominance: facing the consequences of an immunological ménage à trois.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1669, doi. 10.1007/s00262-018-2231-z
By:
- Haeryfar, S. M. Mansour;
- Schell, Todd D.
Publication type:
Article
IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1695, doi. 10.1007/s00262-018-2230-0
By:
- Plaumann, Julian;
- Engelhardt, Melanie;
- Awwad, Mohamed H. S.;
- Echchannaoui, Hakim;
- Amman, Eva;
- Raab, Marc S.;
- Hillengass, Jens;
- Halama, Niels;
- Neuber, Brigitte;
- Müller-Tidow, Carsten;
- Goldschmidt, Hartmut;
- Hundemer, Michael
Publication type:
Article
T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1767, doi. 10.1007/s00262-018-2228-7
By:
- Wieland, Andreas;
- Kamphorst, Alice O.;
- Adsay, N. Volkan;
- Masor, Jonathan J.;
- Sarmiento, Juan;
- Nasti, Tahseen H.;
- Darko, Sam;
- Douek, Daniel C.;
- Xue, Yue;
- Curran, Walter J.;
- Lawson, David H.;
- Ahmed, Rafi
Publication type:
Article
Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1685, doi. 10.1007/s00262-018-2227-8
By:
- Xie, Shan;
- Huang, Jia;
- Qiao, Qin;
- Zang, Wenjuan;
- Hong, Shanjuan;
- Tan, Haidong;
- Dong, Chen;
- Yang, Zhiying;
- Ni, Ling
Publication type:
Article
Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1789, doi. 10.1007/s00262-018-2205-1
By:
- Raaijmakers, Tonke K.;
- Ansems, Marleen
Publication type:
Article
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1753, doi. 10.1007/s00262-018-2199-8
By:
- Wahba, John;
- Natoli, Marina;
- Whilding, Lynsey M.;
- Parente-Pereira, Ana C.;
- Jung, Youngrock;
- Zona, Stefania;
- Lam, Eric W.-F.;
- Smith, J. Richard;
- Maher, John;
- Ghaem-Maghami, Sadaf
Publication type:
Article
Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1673, doi. 10.1007/s00262-018-2225-x
By:
- Kato, Ryo;
- Yamasaki, Makoto;
- Urakawa, Shinya;
- Nishida, Kentaro;
- Makino, Tomoki;
- Morimoto-Okazawa, Akiko;
- Kawashima, Atsunari;
- Iwahori, Kota;
- Suzuki, Susumu;
- Ueda, Ryuzo;
- Mori, Masaki;
- Satoh, Taroh;
- Doki, Yuichiro;
- Wada, Hisashi
Publication type:
Article
Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1709, doi. 10.1007/s00262-018-2224-y
By:
- Neumann, Frank;
- Acker, Fabian;
- Schormann, Claudia;
- Pfreundschuh, Michael;
- Bittenbring, Joerg Thomas
Publication type:
Article
Circulating CD8+ T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patients.
Published in:
Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1743, doi. 10.1007/s00262-018-2213-1
By:
- Lin, Kai-Rong;
- Pang, Dan-Mei;
- Jin, Ya-Bin;
- Hu, Qian;
- Pan, Ying-Ming;
- Cui, Jin-Huan;
- Chen, Xiang-Ping;
- Lin, Yin-Xin;
- Mao, Xiao-Fan;
- Duan, Hai-Bo;
- Luo, Wei
Publication type:
Article

Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 11

TIGIT: a novel immunotherapy target moving from bench to bedside.

Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities.

International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain.

TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma.

Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung.

Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.

PD-1/PD-L1 co-inhibition shapes anticancer T cell immunodominance: facing the consequences of an immunological ménage à trois.

IL-10 inducible CD8<sup>+</sup> regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells.

T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient.

Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors.

Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands.

Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer.

Increased Tim-3<sup>+</sup> T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients.

Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity.

Circulating CD8<sup>+</sup> T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patients.